We shown that, in contrast to classical opioid receptors, ACKR3 doesn't cause classical G protein signaling and is not modulated via the classical prescription or analgesic opioids, including morphine, fentanyl, or buprenorphine, or by nonselective opioid antagonists for instance naloxone. Alternatively, we founded that LIH383, an ACKR3-selective subnanomolar competitor https://fridav950qhx6.mysticwiki.com/user